close 73% of retail accounts lose money when trading CFDs with this provider. Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 73% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
SearchSearch
Change languageEnglish (International)
Dashboard

LLY

1,023.96

+0.31%↑

JNJ

196.01

+0.34%↑

ABBV

232.37

0%↓

UNH

321.37

-3.25%↓

AZN

89.14

+0.64%↑

LLY

1,023.96

+0.31%↑

JNJ

196.01

+0.34%↑

ABBV

232.37

0%↓

UNH

321.37

-3.25%↓

AZN

89.14

+0.64%↑

LLY

1,023.96

+0.31%↑

JNJ

196.01

+0.34%↑

ABBV

232.37

0%↓

UNH

321.37

-3.25%↓

AZN

89.14

+0.64%↑

LLY

1,023.96

+0.31%↑

JNJ

196.01

+0.34%↑

ABBV

232.37

0%↓

UNH

321.37

-3.25%↓

AZN

89.14

+0.64%↑

LLY

1,023.96

+0.31%↑

JNJ

196.01

+0.34%↑

ABBV

232.37

0%↓

UNH

321.37

-3.25%↓

AZN

89.14

+0.64%↑

Home・Stock List・Karyopharm Therapeutics Inc
Search

Karyopharm Therapeutics Inc

Closed

SectorHealthcare

5.61 4.08

Strong Buy

Price update 14 Nov 2025, 20:57 UTC

BuySell

Overview

Share price change

24h

Current

Min

5.36

Max

5.82

Key metrics

By Trading Economics

Income

4.1M

-33M

Sales

6.1M

44M

EPS

-3.82

Profit margin

-75.213

Employees

279

EBITDA

9.2M

-15M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+147.41% upside

Market Stats

By TradingEconomics

Market Cap

-14M

88M

Previous open

1.53

Previous close

5.61

News Sentiment

By Acuity

50%

50%

171 / 374 Healthcare

Technical Score

By Trading Central

Confidence

Bullish Evidence

5.9501 / 7.66 Support & Resistance

Karyopharm Therapeutics Inc Chart

Past performance is not a reliable indicator of future results.

Related News

13 Nov 2025, 21:34 UTC

Earnings

Applied Materials 4Q Sales Fall; Forecasts Higher Demand in 2H26

DJ

Read

13 Nov 2025, 23:45 UTC

Market Talk

Nikkei May Fall After Wall Street's Weakness -- Market Talk

DJ

Read

13 Nov 2025, 23:42 UTC

Acquisitions, Mergers, Takeovers

Paramount, Comcast, Netflix Prepare Bids for Warner As Deadline Approaches -- 4th Update

DJ

Read

13 Nov 2025, 23:41 UTC

Market Talk

Gold Edges Higher on Possible Dip-Buying -- Market Talk

DJ

Read

13 Nov 2025, 23:24 UTC

Earnings

JBS NV: Robust U.S. Beef Demand Supported 3Q North America Sales >JBS

DJ

Read

13 Nov 2025, 23:24 UTC

Earnings

JBS NV: Live Cattle Prices Have Remained High, Pressuring Profitability >JBS

DJ

Read

13 Nov 2025, 23:23 UTC

Earnings

JBS NV 3Q EPS 52c >JBS

DJ

Read

13 Nov 2025, 23:23 UTC

Earnings

JBS NV 3Q Sales $22.6B >JBS

DJ

Read

13 Nov 2025, 23:04 UTC

Market Talk

RBA Looks Set To Remain Sidelined For a While Yet -- Market Talk

DJ

Read

13 Nov 2025, 22:02 UTC

Earnings

Nu Holdings 3Q Net $783M >NU

DJ

Read

13 Nov 2025, 22:01 UTC

Earnings

Nu Holdings 3Q Rev $4.2B >NU

DJ

Read

13 Nov 2025, 21:51 UTC

Acquisitions, Mergers, Takeovers

Paramount, Comcast, Netflix Prepare Bids for Warner As Deadline Approaches -- 3rd Update

DJ

Read

13 Nov 2025, 21:50 UTC

Earnings

Disney Posts Roughly Flat Quarterly Revenue as TV Declines Continue -- 4th Update

DJ

Read

13 Nov 2025, 21:45 UTC

Acquisitions, Mergers, Takeovers

Paramount, Comcast, Netflix Prepare Bids for Warner As Deadline Approaches -- 2nd Update

DJ

Read

13 Nov 2025, 21:41 UTC

Acquisitions, Mergers, Takeovers

Paramount, Comcast, Netflix Prepare Bids for Warner As Deadline Approaches -- Update

DJ

Read

13 Nov 2025, 21:36 UTC

Acquisitions, Mergers, Takeovers

Paramount Plans to Bid for All of Warner Bros., Sources Say -- WSJ

DJ

Read

13 Nov 2025, 21:36 UTC

Acquisitions, Mergers, Takeovers

Paramount, Comcast, Netflix Among Potential Bidders That Have Looked at Warner Bros. Financials, Sources Say -- WSJ

DJ

Read

13 Nov 2025, 21:36 UTC

Acquisitions, Mergers, Takeovers

Paramount, Comcast, Netflix Prepare Bids for Warner As Deadline Approaches -- WSJ

DJ

Read

13 Nov 2025, 21:36 UTC

Acquisitions, Mergers, Takeovers

Netflix, Comcast Each Considering Pursuing Warner Bros. Studio, Streaming Assets, Sources Say -- WSJ

DJ

Read

13 Nov 2025, 21:36 UTC

Acquisitions, Mergers, Takeovers

Bids for Warner Bros. Discovery Due Next Week, Sources Say -- WSJ

DJ

Read

13 Nov 2025, 21:33 UTC

Market Talk

Banks See CAD Appreciation Through 2026, Trade Poses 'Clear' Risk -- Market Talk

DJ

Read

13 Nov 2025, 21:33 UTC

Earnings

If Investors Like Rocket Lab Stock, They Should Love Firefly Shares -- Barrons.com

DJ

Read

13 Nov 2025, 21:31 UTC

Earnings

Applied Materials Stock Falls Despite Strong Earnings -- Barrons.com

DJ

Read

13 Nov 2025, 21:25 UTC

Earnings

Figure Tech Solutions 3Q Rev $156.4M >FIGR

DJ

Read

13 Nov 2025, 21:25 UTC

Earnings

Figure Tech Solutions 3Q EPS 34c >FIGR

DJ

Read

13 Nov 2025, 21:23 UTC

Earnings

Intchains Group 3Q Rev $1.3M >ICG

DJ

Read

13 Nov 2025, 21:03 UTC

Earnings

Applied Materials Sees 1Q Rev $6.35B-$7.35B >AMAT

DJ

Read

13 Nov 2025, 21:02 UTC

Earnings

Applied Materials Sees 1Q Adj EPS $1.98-Adj EPS $2.38 >AMAT

DJ

Read

13 Nov 2025, 21:01 UTC

Earnings

Applied Materials 4Q Rev $6.8B >AMAT

DJ

Read

13 Nov 2025, 21:01 UTC

Earnings

Applied Materials 4Q Gross Margin 48.0% >AMAT

DJ

Read

Peer Comparison

Price change

Karyopharm Therapeutics Inc Forecast

Price Target

By TipRanks

147.41% upside

12 Months Forecast

Average 13.83 USD  147.41%

High 21 USD

Low 6 USD

Based on 6 Wall Street analysts offering 12 month price targets forKaryopharm Therapeutics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

6 ratings

5

Buy

1

Hold

0

Sell

Based on 6 analysts giving stock ratings to Karyopharm Therapeutics Inc - Dist in the past 3 months.

Technical Score

By Trading Central

5.9501 / 7.66Support & Resistance

Short Term

Bullish Evidence

Recent bullish events outweigh bearish events.

Intermediate Term

Strong Bearish Evidence

All events are bearish.

Long Term

No Evidence

There are no events.

Sentiment

By Acuity

171 / 374 Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

Other stocks from the sector

LLY

Eli Lilly and Co.

1,023.96

↑ +0.31%

JNJ

Johnson and Johnson

196.01

↑ +0.34%

ABBV

AbbVie Inc

232.37

↓0%

UNH

UnitedHealth Group Inc

321.37

↓-3.25%

AZN

AstraZeneca PLC ADR

89.14

↑ +0.64%
help-icon Live chat